Griffith University has been awarded nearly $1.4 million in National Health and Medical Research Council funding to develop new classes of antibiotics, further work around mosquito-borne viruses and improve outcomes for people with acute mental illness.
Research conducted by Griffith University and Melbourne-based company Paradigm Biopharmaceuticals Limited has uncovered a potential new therapeutic treatment in the global battle against mosquito-borne alphavirus infections, including the debilitating Ross River Virus and Chikungunya Virus.
Innovative Australian scientist Dr Ali Zaid has joined Griffith University’s Institute for Glycomics to lead a project on Ross River Fever. Dr Zaid is one of only a handful of scientists who have the skills and knowledge to capture real-time images of viruses and observe the life and the immune response deep within living tissue. […]